148 related articles for article (PubMed ID: 31778299)
1. Decreased microcirculatory function measured by perfusion index is a novel indicator of diabetic kidney disease in patients with type 2 diabetes.
Okada H; Tanaka M; Yasuda T; Okada Y; Norikae H; Fujita T; Nishi T; Oyamada H; Yamane T; Fukui M
J Diabetes Investig; 2020 May; 11(3):681-687. PubMed ID: 31778299
[TBL] [Abstract][Full Text] [Related]
2. Decreased microcirculatory function measured by perfusion index is predictive of cardiovascular death.
Okada H; Tanaka M; Yasuda T; Okada Y; Norikae H; Fujita T; Nishi T; Oyamada H; Yamane T; Fukui M
Heart Vessels; 2020 Jul; 35(7):930-935. PubMed ID: 32062766
[TBL] [Abstract][Full Text] [Related]
3. High normal albuminuria is independently associated with aortic stiffness in patients with Type 2 diabetes.
Liu JJ; Tavintharan S; Yeoh LY; Sum CF; Ng XW; Pek SL; Lee SB; Tang WE; Lim SC;
Diabet Med; 2014 Oct; 31(10):1199-204. PubMed ID: 24702136
[TBL] [Abstract][Full Text] [Related]
4. Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: a post hoc analysis (ORIENT-blood pressure).
Imai E; Ito S; Haneda M; Harada A; Kobayashi F; Yamasaki T; Makino H; Chan JC
Nephrol Dial Transplant; 2016 Mar; 31(3):447-54. PubMed ID: 26152402
[TBL] [Abstract][Full Text] [Related]
5. Decreased peripheral perfusion measured by perfusion index is a novel indicator for cardiovascular death in patients with type 2 diabetes and established cardiovascular disease.
Okada H; Tanaka M; Yasuda T; Okada Y; Norikae H; Fujita T; Nishi T; Oyamada H; Yamane T; Fukui M
Sci Rep; 2021 Jan; 11(1):2135. PubMed ID: 33483575
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease.
Di Marco M; Scilletta S; Miano N; Marrano N; Natalicchio A; Giorgino F; Di Mauro S; Filippello A; Scamporrino A; Tribulato P; Bosco G; Di Giacomo Barbagallo F; Scicali R; Milluzzo A; Ballirò T; Frittitta L; Castellino P; Purrello F; Piro S; Di Pino A
Cardiovasc Diabetol; 2023 Dec; 22(1):344. PubMed ID: 38093293
[TBL] [Abstract][Full Text] [Related]
7. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
[TBL] [Abstract][Full Text] [Related]
8. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.
Carlsson AC; Östgren CJ; Nystrom FH; Länne T; Jennersjö P; Larsson A; Ärnlöv J
Cardiovasc Diabetol; 2016 Feb; 15():40. PubMed ID: 26928194
[TBL] [Abstract][Full Text] [Related]
9. Peripheral perfusion, measured by perfusion index, is a novel indicator for renal events in patients with type 2 diabetes mellitus.
Okada H; Tanaka M; Yasuda T; Okada Y; Norikae H; Fujita T; Nishi T; Oyamada H; Yamane T; Fukui M
Sci Rep; 2020 Apr; 10(1):6054. PubMed ID: 32269240
[TBL] [Abstract][Full Text] [Related]
10. Systolic blood pressure as a predictor of incident albuminuria and rapid renal function decline in type 2 diabetic patients.
Sheen YJ; Lin JL; Li TC; Bau CT; Sheu WH
J Diabetes Complications; 2014; 28(6):779-84. PubMed ID: 25219331
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
[TBL] [Abstract][Full Text] [Related]
12. Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study).
Kinguchi S; Wakui H; Ito Y; Kondo Y; Azushima K; Osada U; Yamakawa T; Iwamoto T; Yutoh J; Misumi T; Aoki K; Yasuda G; Yoshii T; Yamada T; Ono S; Shibasaki-Kurita T; Hosokawa S; Orime K; Hanaoka M; Sasaki H; Inazumi K; Yamada T; Kobayashi R; Ohki K; Haruhara K; Kobayashi Y; Yamanaka T; Terauchi Y; Tamura K
Cardiovasc Diabetol; 2019 Aug; 18(1):110. PubMed ID: 31455298
[TBL] [Abstract][Full Text] [Related]
13. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes.
Okada H; Fukui M; Tanaka M; Inada S; Mineoka Y; Nakanishi N; Senmaru T; Sakabe K; Ushigome E; Asano M; Yamazaki M; Hasegawa G; Nakamura N
Atherosclerosis; 2012 Jan; 220(1):155-9. PubMed ID: 22100253
[TBL] [Abstract][Full Text] [Related]
14. Early vascular parameters in the micro- and macrocirculation in type 2 diabetes.
Kannenkeril D; Bosch A; Harazny J; Karg M; Jung S; Ott C; Schmieder RE
Cardiovasc Diabetol; 2018 Sep; 17(1):128. PubMed ID: 30231923
[TBL] [Abstract][Full Text] [Related]
15. A difference in systolic blood pressure between arms is a novel predictor of the development and progression of diabetic nephropathy in patients with type 2 diabetes.
Okada H; Fukui M; Tanaka M; Matsumoto S; Iwase H; Kobayashi K; Asano M; Yamazaki M; Hasegawa G; Nakamura N
Atherosclerosis; 2013 Oct; 230(2):198-201. PubMed ID: 24075744
[TBL] [Abstract][Full Text] [Related]
16. Value of Estimated Glomerular Filtration Rate and Albuminuria in Predicting Cardiovascular Risk in Patients with Type 2 Diabetes without Cardiovascular Disease.
Weerarathna T; Liyanage G; Herath M; Weerarathna M; Amarasinghe I
Biomed Res Int; 2018; 2018():8178043. PubMed ID: 30729117
[TBL] [Abstract][Full Text] [Related]
17. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.
McMullan CJ; Lambers Heerspink HJ; Parving HH; Dwyer JP; Forman JP; de Zeeuw D
Am J Kidney Dis; 2014 Nov; 64(5):714-22. PubMed ID: 25064674
[TBL] [Abstract][Full Text] [Related]
18. The prognosis of subjects showing a reduced estimated glomerular filtration rate without albuminuria in Japanese patients with type 2 diabetes: a cohort study for diabetic kidney disease.
Ito H; Antoku S; Izutsu T; Kusano E; Matsumoto S; Yamasaki T; Mori T; Togane M
Clin Exp Nephrol; 2020 Nov; 24(11):1033-1043. PubMed ID: 32734506
[TBL] [Abstract][Full Text] [Related]
19. Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes.
De Cosmo S; Rossi MC; Pellegrini F; Lucisano G; Bacci S; Gentile S; Ceriello A; Russo G; Nicolucci A; Giorda C; Viazzi F; Pontremoli R;
Nephrol Dial Transplant; 2014 Mar; 29(3):657-62. PubMed ID: 24398892
[TBL] [Abstract][Full Text] [Related]
20. Protein intake is not associated with progression of diabetic kidney disease in patients without macroalbuminuria.
Kaji A; Hashimoto Y; Kobayashi Y; Wada S; Kuwahata M; Yamazaki M; Fukui M
Diabetes Metab Res Rev; 2019 Jul; 35(5):e3150. PubMed ID: 30860658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
